577 related articles for article (PubMed ID: 16050054)
1. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
2. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
Castaño G; Mas R; Fernández L; Illnait J; Mesa M; Alvarez E; Lezcay M
Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
[TBL] [Abstract][Full Text] [Related]
4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
[TBL] [Abstract][Full Text] [Related]
6. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Castaño G; Más R; Fernández JC; Fernández L; Illnait J; López E
Drugs R D; 2002; 3(3):159-72. PubMed ID: 12099160
[TBL] [Abstract][Full Text] [Related]
7. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
Pons P; Rodríguez M; Robaina C; Illnait J; Más R; Fernández L; Fernández JC
Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
[TBL] [Abstract][Full Text] [Related]
8. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
9. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
10. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.
Castaño G; Arruzazabala ML; Fernández L; Mas R; Carbajal D; Molina V; Illnait J; Mendoza S; Gámez R; Mesa M; Fernández J
Curr Ther Res Clin Exp; 2006 May; 67(3):174-92. PubMed ID: 24678094
[TBL] [Abstract][Full Text] [Related]
12. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
Castaño G; Más R; Fernández J; López E; Illnait J; Fernández L; Mesa M
Curr Ther Res Clin Exp; 2003 Sep; 64(8):522-37. PubMed ID: 24944402
[TBL] [Abstract][Full Text] [Related]
13. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
Castaño G; Más R; Fernández L; Fernández JC; Illnait J; López LE; Alvarez E
Gynecol Endocrinol; 2000 Jun; 14(3):187-95. PubMed ID: 10923280
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
[TBL] [Abstract][Full Text] [Related]
16. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
17. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
Greyling A; De Witt C; Oosthuizen W; Jerling JC
Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
[TBL] [Abstract][Full Text] [Related]
18. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
Canetti M; Moreira M; Mas R; Illnait J; Fernandez L; Fernandez J; Diaz E; Castano G
Int J Clin Pharmacol Res; 1995; 15(4):159-65. PubMed ID: 8871266
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
Castaño G; Fernández L; Mas R; Illnait J; Fernández J; Mesa M; Alvarez E; Lezcay M
Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
[TBL] [Abstract][Full Text] [Related]
20. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Castaño G; Más R; Gámez R; Fernández L; Illnait J
Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]